Maintenance of efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.

  2013cited by this paper
• The use of lisdexamfetamine dimesylate for the treatment of ADHD

  2012cited by this paper
• Maintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal design.

  2012cited by this paper
• Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

  2011cited by this paper
• ADHD : Clinical Practice Guideline for the Diagnosis , Evaluation , and Treatment of Attention-Deficit / Hyperactivity Disorder in Children and Adolescents

  2011cited by this paper
• Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

  2010cited by this paper
• Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study.

  2010cited by this paper
• Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design

  2010cited by this paper
• A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

  2010cited by this paper
• A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

  2009cited by this paper
• Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study.

  2007cited by this paper
• Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit / Hyperactivity Disorder

  2007cited by this paper
• A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.

  2007cited by this paper
• The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

  2007cited by this paper
• Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Long-acting medications for the hyperkinetic disorders

  2006cited by this paper
• Relapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. A randomized, double-blind, placebo-controlled trial.

  1997cited by this paper
• Child and Adolescent Psychiatry and Mental Health a 13-hour Laboratory School Study of Lisdexamfetamine Dimesylate in School-aged Children with Attention-deficit/hyperactivity Disorder

  year unknowninfluential reference

• Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report

  2022influential citation
• The management of ADHD in children and adolescents: bringing evidence to the clinic: perspective from the European ADHD Guidelines Group (EAGG)

  2021cites this paper
• Evidence-based pharmacological treatment options for ADHD in children and adolescents.

  2021cites this paper
• Psychostimulants: Primary and Secondary Indications

  2021cites this paper
• Intentional Discontinuation of Psychostimulants Used to Treat ADHD in Youth: A Review and Analysis

  2021cites this paper
• Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder

  2020cites this paper
• Post hoc analyses of response rates to pharmacological treatments in children and adolescents with attention-deficit/hyperactivity disorder

  2020cites this paper
• Relationship Between Treatment Duration and Efficacy of Pharmacological Treatment for ADHD: A Meta-Analysis and Meta-Regression of 87 Randomized Controlled Clinical Trials

  2020cites this paper
• Attention-Deficit/Hyperactivity Disorder Clinical Practice Guideline

  2020cites this paper
• Review of lisdexamfetamine dimesylate in children and adolescents with attention deficit/hyperactivity disorder

  2020cites this paper
• Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses

  2020cites this paper
• Effect of Continuing and Discontinuing Medications on Quality of Life After Symptomatic Remission in Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis.

  2020cites this paper
• Withdrawal Confounding in Randomized Controlled Trials of Antipsychotic, Antidepressant, and Stimulant Drugs, 2000–2017

  2019cites this paper
• Discontinuing Psychotropic Drugs from Participants in Randomized Controlled Trials: A Systematic Review

  2019cites this paper
• Debate: Are Stimulant Medications for Attention-Deficit/Hyperactivity Disorder Effective in the Long Term? (For).

  2019cites this paper
• Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD

  2018influential citation
• Experiencia en la utilización de lisdexanfetamina en el manejo del TDAH de niños y adolescentes

  2018cites this paper
• University of Dundee Cognitive Function of Children and Adolescents with Attention-Deficit / Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine

  2018influential citation
• Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate

  2018influential citation
• University of Dundee Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit / Hyperactivity Disorder

  2018cites this paper
• Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2018cites this paper
• Is Lisdexamfetamine Dimesylate Safe and Effective in Reducing ADHD Symptoms

  2017cites this paper
• Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

  2017cites this paper
• University of Dundee Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD

  2017cites this paper
• Efficacy and Tolerability of Different Interventions in Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2017cites this paper
• Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy

  2016cites this paper
• Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

  2016cites this paper
• Psychometric validation of the Weiss Functional Impairment Rating Scale-Parent Report Form in children and adolescents with attention-deficit/hyperactivity disorder

  2015cites this paper
• Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials

  2015influential citation
• Practical pharmacotherapy in child psychiatry: an update

  2015cites this paper
• Atomoxetine in patients with ADHD: A clinical and pharmacological review of the onset, trajectory, duration of response and implications for patients

  2015influential citation
• Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes

  2015cites this paper
• Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate

  2015cites this paper
• Attention-deficit/hyperactivity disorder Under Treatment Outcomes Research (AUTOR): a European observational study in pediatric subjects

  2015influential citation
• A Systematic Review of the Safety of Lisdexamfetamine Dimesylate

  2014cites this paper
• Health-Related Quality of Life and Functional Outcomes from a Randomized-Withdrawal Study of Long-Term Lisdexamfetamine Dimesylate Treatment in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2014cites this paper
• Evaluation of a head-to-head study of lisdexamfetamine dimesylate and atomoxetine

  2014cites this paper